Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Hanyang University Guri Hospital, Guri, Republic of Korea.
Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Hanyang University Seoul Hospital, 222 Wangsimni-ro, Sungdong-gu, Seoul, 04763, Republic of Korea.
Sci Rep. 2024 Sep 2;14(1):20310. doi: 10.1038/s41598-024-71060-8.
Optimal blood pressure (BP) for patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains unclear. This study aims to identify the optimal BP by investigating the association between average office BP and future clinical events in patients undergoing PCI. Consecutive patients undergoing PCI from 2012 to 2016 were included. They were divided into five groups according to the average follow-up BP after discharge. The co-primary outcomes were net adverse clinical events (NACE) and major adverse cardiac and cerebrovascular events (MACCE) up to 5 years. NACE was defined as a composite of MACCE (all-cause death, non-fatal myocardial infarction (MI), non-fatal stroke, or any revascularization) or major bleeding. A total of 2845 patients were included, and among them, 787 (27.7%) experienced the NACE during the follow-up period. Patients in the highest SBP group (adjusted hazard ratio [HR] 1.495, confidence interval [CI] 1.189-1.880) and lowest SBP group (adjusted HR 1.625, CI 1.214-2.176) had a significantly higher risk of 5-year NACE. Similar associations were observed between SBP and the risk of MACCE, and similar results based on DBP categories were also observed. There was a J-curve relationship between SBP and DBP with respect to 5-year NACE and MACCE. The nadir point of risk for NACE and MACCE was found at 121.4/74.8 and 120.4/73.7 mmHg. In patients underwent PCI, there is a significant correlation between office BP level and clinical events, indicates the importance of efforts for optimal BP control to reduce ischemic and bleeding events.Trial registration: HanYang University Medical Center (HYUMC) Registry, NCT05935397.
在接受经皮冠状动脉介入治疗(PCI)的冠心病(CAD)患者中,最佳血压(BP)仍不清楚。本研究旨在通过研究 PCI 后平均诊室 BP 与未来临床事件之间的关系来确定最佳 BP。
连续纳入 2012 年至 2016 年接受 PCI 的患者。根据出院后随访 BP 的平均值,将其分为五组。主要复合终点为 5 年内的净不良临床事件(NACE)和主要不良心脏和脑血管事件(MACCE)。NACE 定义为 MACCE(全因死亡、非致死性心肌梗死(MI)、非致死性卒中和任何血运重建)或大出血的复合终点。共纳入 2845 例患者,其中 787 例(27.7%)在随访期间发生 NACE。SBP 最高组(校正后的危险比 [HR] 1.495,置信区间 [CI] 1.189-1.880)和最低 SBP 组(校正后的 HR 1.625,CI 1.214-2.176)发生 5 年 NACE 的风险显著升高。SBP 与 MACCE 风险之间也存在类似的关联,基于 DBP 分类也观察到类似的结果。SBP 和 DBP 与 5 年 NACE 和 MACCE 之间存在 J 形关系。NACE 和 MACCE 风险的最低点在 121.4/74.8 和 120.4/73.7mmHg。在接受 PCI 的患者中,诊室 BP 水平与临床事件之间存在显著相关性,表明努力控制最佳 BP 以减少缺血和出血事件的重要性。
韩阳大学医疗中心(HYUMC)登记处,NCT05935397。